Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Aug 1;84(2):210-219.
doi: 10.1097/FJC.0000000000001584.

Clinical Characteristics, Management, and Outcomes in Cardiogenic Shock: Insights From a High-Volume Italian Cardiac Intensive Care Unit

Affiliations
Observational Study

Clinical Characteristics, Management, and Outcomes in Cardiogenic Shock: Insights From a High-Volume Italian Cardiac Intensive Care Unit

Marco Giuseppe Del Buono et al. J Cardiovasc Pharmacol. .

Abstract

Cardiogenic shock (CS) is a life-threatening condition. The aim of this study is to evaluate the clinical characteristics, management, and complication rate of patients with CS admitted to a high-volume hospital in Italy. We retrospectively reviewed the clinical, echocardiographic, and laboratory data, therapeutic management, and outcomes of patients with CS admitted to the Policlinico Gemelli (Rome) between January 1, 2020, and January 1, 2023. We included 96 patients [median age 71 years, interquartile range 60-79; 65 (68%) males], of whom 49 patients (51%) presented CS secondary to acute myocardial infarction and 60 (63%) with a de novo presentation of CS. Dobutamine was the most frequently used inotrope and noradrenaline the most frequently used vasopressor (adopted in 56% and 82% of cases, respectively). Forty-five (47%) patients died during the hospitalization. Nonsurvivors were older and had a higher inflammatory burden at admission, elevated lactate levels, a greater increase in lactate levels, higher left ventricular filling pressures, and worse right ventricular function. C-reactive protein levels [odds ratio (OR) 1.03, 95% confidence interval (CI) (1.00-1.04), P = 0.027], lactate levels at admission (OR 3.49, 95% CI, 1.59-7.63, P = 0.02), and increase in lactate levels (OR 2.8, 95% CI, 1.37-5.75, P = 0.005) were independent predictors of in-hospital all-cause death. Our data contribute to the assessment of the regional variations in the management and outcomes of patients with CS. We observed a high mortality and complication rate. Lactate acidosis and C-reactive protein measured at admission may help in identifying patients at higher risk of adverse in-hospital outcomes.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

FIGURE 1.
FIGURE 1.
Clinical characteristics of the population cohort of patients with CS. This figure illustrates the demographic characteristics (age, sex, comorbidities), the clinical presentations on admission according to the SCAI shock stage, the etiology, and the treatments administrated in our cohort of patients with CS.
FIGURE 2.
FIGURE 2.
Prevalence of in-hospital complications among patients with CS. This figure illustrates the distribution of in-hospital complications among our population cohort of patients with CS and survivors versus nonsurvivors.
FIGURE 3.
FIGURE 3.
ROC curve analysis for CRP to predict in-hospital complications. ROC curve analysis showed an AUC for CRP levels to predict in-hospital mortality of 0.793 (P < 0.01).
FIGURE 4.
FIGURE 4.
Correlation between CRP at admission and delta interval changes in lactic acid levels. The scatterplot graph illustrates the correlation between delta interval changes in lactic acid levels and CRP at admission (R = +0.326, P = 0.01).

References

    1. Chioncel O, Parissis J, Mebazaa A, et al. . Epidemiology, pathophysiology and contemporary management of cardiogenic shock: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22:1315–1341. - PubMed
    1. Hochman JS, Sleeper LA, Webb JG, et al. . Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511–2515. - PMC - PubMed
    1. Thiele H, Zeymer U, Thelemann N, et al. . Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial. Circulation. 2019;139:395–403. - PubMed
    1. Vallabhajosyula S, Bhopalwala HM, Sundaragiri PR, et al. . Cardiogenic shock complicating non-ST-segment elevation myocardial infarction: an 18 year study. Am Heart J. 2022;244:54–65. - PubMed
    1. Wayangankar SA, Bangalore S, McCoy LA, et al. . Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI registry. JACC Cardiovasc Interv. 2016;9:341–351. - PubMed

Publication types